Signaling pathways in the regulation of cytokine release syndrome in human diseases and intervention therapy

Cytokine release syndrome (CRS) embodies a mixture of clinical manifestations, including elevated circulating cytokine levels, acute systemic inflammatory symptoms and secondary organ dysfunction, which was first described in the context of acute graft-versus-host disease after allogeneic hematopoie...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xia, Shao, Mi, Zeng, Xiangjun, Qian, Pengxu, Huang, He
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526712/
https://www.ncbi.nlm.nih.gov/pubmed/34667157
http://dx.doi.org/10.1038/s41392-021-00764-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526712/
https://www.ncbi.nlm.nih.gov/pubmed/34667157
http://dx.doi.org/10.1038/s41392-021-00764-4

Ejemplares similares